SEC Comment Letter for TECOGEN INC. (TGEN) (CIK 0001537435) (TGEN) — Jul 16, 2015
TECOGEN INC. (TGEN) (CIK 0001537435)
Date: July 16, 2015 · CIK: 0001537435 · Accession: 0000000000-15-037105
AI Filing Summary & Sentiment
File numbers found in text: 333-205147
Show Raw Text
July 16, 2015
Via E -mail
Michael S. Rispin
Corporate & Securities Counsel
Tecogen Inc.
45 First Avenue
Waltham, MA 02451
Re: Tecogen Inc.
Registration Statement on Form S-3
Filed June 22, 2015
File No. 333-205147
Dear Mr. Rispin :
We have limited our review of your registration statement to those issues we have
addressed in our comments. In some of our comments, we may ask you to provide us with
information so we may better understand your disclosure.
Please respond to this letter by amending your registration statement and providing the
requested information . If you do not believe our com ments apply to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
After reviewing any amendment to your registration statement and the information you
provide in response to these comments, w e may have additional comments.
Form S -3
Auditor’s Consent
1. We have read your response to comments one and two from our oral comments issued July 9,
2015. Item 12(a)(1) of Form S -3 requires you to specifically incorporate by reference your
latest annu al report on Form 10 -K that contains financial statements for your latest fiscal
year. As required by Rule 8 -02 of Regulation S -X, your Form 10 -K for the year ended
December 31, 2014 includes audited balance sheets as of December 31, 2014 and 2013 and
audited statements of income, cash flows and changes in stockholders’ equity for each of the
years then ended. You therefore must provide a consent for the use of McGladrey LLC’s
report dated March 24, 2014. Please also refer to your reliance on this report in the Experts
section on page six.
Michael S. Rispin
Tecogen Inc.
July 16, 2015
Page 2
We urge all persons who are responsible for the accuracy and adequacy of the disclosure
in the filing to be certain that the filing includes the information the Securities Act of 193 3 and
all applicable Securities Act rules require. Since the company and its management are in
possession of all facts relating to a company’s disclosure, they are responsible for the accuracy
and adequacy of the disclosures they have made.
Notwithstanding our comments, in the event you request acceleration of the effective date
of the pending registration statement , please provide a written statement from the company
acknowledging that:
should the Commission or the staff, acting pursuant to delegated authority, declare the
filing effective, it does not foreclose the Commission from taking any action with respect
to the filing;
the action of the Commission or the staff, acting pursuant to delegated authority, in
declaring the filing effective, does not relieve the company from its full responsibility for
the adequacy and accuracy of the disclosure in the filing; and
the company may not assert staff comments and the declaration of effectiveness as a
defense in any proceeding initiated by the Commission or any person under the federal
securities laws of the United States.
Please refer to Rules 460 and 461 regarding requests for acceleration . We will consider a
written request for acceleration of the effective date of the registration statement as confirmation
of the fact that those requesting acceleration are aware of their respective responsibilities under
the Securities Act of 1933 and the Securities Exchange Act of 1934 as they relate to the proposed
public offering of the securities specified in the above registration statement. Please allow
adequate time for us to review any amendment prior to the requested effective date of the
registration statement.
You may contact Tracey McKoy, Staff Accountant, at (202) 551 -3772 or Jeanne Baker,
Assistant Chief Accountant, at (202) 551 -3691 if you have questions regarding comments on the
financial statements and re lated matters. Please contact Asia Timmons -Pierce, Staff Attorney, at
(202) 551 -3754 or me at (202) 551 -3765 with any other questions.
Sincerely,
/s/ Pamela Long
Pamela Long
Assistant Director
Michael S. Rispin
Tecogen Inc.
July 16, 2015
Page 3
cc: Benjamin Armou r (via email )
Sullivan & Worcester LLP